CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Preferred stock Series A preferred stock	Preferred stock Series B preferred stock	Common stock	Paid-in capital	Retained earnings	Treasury stock	Accum other comp loss
Beginning Balance at Dec. 31, 2022	$ 365,392	$ 1	$ 15	$ 345	$ 213,937	$ 250,549	$ (67,780)	$ (31,675)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred dividends paid	(23)					(23)
Compensation expense for restricted stock	476				476
Tax related items for share based awards	(104)				(104)
Currency translation adjustment	98							98
Repurchases of shares	(9,135)						(9,135)
Net income	17,580					17,580
Ending Balance at Mar. 31, 2023	374,284	1	15	345	214,309	268,106	(76,915)	(31,577)
Beginning Balance at Dec. 31, 2022	365,392	1	15	345	213,937	250,549	(67,780)	(31,675)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	52,806
Ending Balance at Sep. 30, 2023	363,576	1	15	345	215,684	303,288	(123,995)	(31,762)
Beginning Balance at Mar. 31, 2023	374,284	1	15	345	214,309	268,106	(76,915)	(31,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred dividends paid	(22)					(22)
Compensation expense for restricted stock	871				871
Tax related items for share based awards	(328)				(328)
Currency translation adjustment	659							659
Repurchases of shares	(25,053)						(25,053)
Net income	19,054					19,054
Ending Balance at Jun. 30, 2023	369,465	1	15	345	214,852	287,138	(101,968)	(30,918)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred dividends paid	(22)					(22)
Compensation expense for restricted stock	864				864
Tax related items for share based awards	(32)				(32)
Currency translation adjustment	(844)							(844)
Repurchases of shares	(22,027)						(22,027)
Net income	16,172					16,172
Ending Balance at Sep. 30, 2023	363,576	1	15	345	215,684	303,288	(123,995)	(31,762)
Beginning Balance at Dec. 31, 2023	380,879	1	15	345	216,482	319,271	(123,995)	(31,240)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred dividends paid	(23)					(23)
Compensation expense for restricted stock	864				864
Tax related items for share based awards	(54)				(54)
Currency translation adjustment	(614)							(614)
Repurchases of shares	(16,920)						(16,920)
Net income	11,332					11,332
Ending Balance at Mar. 31, 2024	375,464	1	15	345	217,292	330,580	(140,915)	(31,854)
Beginning Balance at Dec. 31, 2023	380,879	1	15	345	216,482	319,271	(123,995)	(31,240)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	49,126
Ending Balance at Sep. 30, 2024	402,368	1	15	345	218,062	368,329	(153,003)	(31,381)
Beginning Balance at Mar. 31, 2024	375,464	1	15	345	217,292	330,580	(140,915)	(31,854)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred dividends paid	(22)					(22)
Compensation expense for restricted stock	1,212				1,212
Tax related items for share based awards	(1,701)				(1,701)
Currency translation adjustment	93							93
Repurchases of shares	(7,058)						(7,058)
Net income	16,693					16,693
Ending Balance at Jun. 30, 2024	384,681	1	15	345	216,803	347,251	(147,973)	(31,761)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred dividends paid	(23)					(23)
Compensation expense for restricted stock	1,322				1,322
Tax related items for share based awards	(63)				(63)
Currency translation adjustment	380							380
Repurchases of shares	(5,030)						(5,030)
Net income	21,101					21,101
Ending Balance at Sep. 30, 2024	$ 402,368	$ 1	$ 15	$ 345	$ 218,062	$ 368,329	$ (153,003)	$ (31,381)